News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
584,914 Results
Type
Article (20725)
Company Profile (325)
Press Release (563858)
Multimedia
Podcasts (114)
Webinars (15)
Section
Business (195361)
Career Advice (437)
Deals (29982)
Drug Delivery (54)
Drug Development (71343)
Employer Resources (39)
FDA (12344)
Job Trends (10602)
News (286374)
Policy (22253)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1249)
Accelerated approval (42)
ADA (38)
Adcomms (16)
Allergies (148)
Alliances (41281)
ALS (216)
Alzheimer's disease (1509)
Antibody-drug conjugate (ADC) (533)
Approvals (12940)
Artificial intelligence (584)
ASCO (271)
Autoimmune disease (346)
Automation (37)
Bankruptcy (301)
Best Places to Work (8540)
BIO (65)
Biologics (2)
BIOSECURE Act (6)
Biosimilars (178)
BioSpace Insights (83)
Biotechnology (229)
Bladder cancer (178)
Brain cancer (64)
Breast cancer (691)
Cancer (5593)
Cardiovascular disease (408)
Career advice (374)
Career pathing (14)
CAR-T (330)
CDC (8)
Celiac Disease (1)
Cell therapy (900)
Cervical cancer (43)
Clinical research (63557)
Collaboration (2052)
Commercialization (6)
Company closure (3)
Compensation (1564)
Complete response letters (76)
COVID-19 (1444)
CRISPR (124)
C-suite (1155)
Cystic fibrosis (145)
Data (7983)
Denatured (26)
Depression (164)
Dermatology (96)
Diabetes (500)
Diagnostics (4898)
Digital health (47)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (356)
Drug pricing (60)
Drug shortages (5)
Duchenne muscular dystrophy (327)
Earnings (81476)
Editorial (37)
Employer branding (6)
Employer resources (37)
Events (103657)
Executive appointments (995)
FDA (15902)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1662)
Gene editing (261)
Generative AI (43)
Gene therapy (726)
GLP-1 (691)
Government (1759)
Grass and pollen (4)
Guidances (340)
Healthcare (12077)
Hematology (147)
HIV (68)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (107)
Immunology and inflammation (281)
Immuno-oncology (98)
Indications (206)
Infectious disease (1706)
Inflammatory bowel disease (205)
Inflation Reduction Act (12)
Influenza (94)
Intellectual property (310)
Interviews (57)
IPO (14440)
IRA (14)
Job creations (2426)
Job search strategy (338)
JPM (41)
Kidney cancer (20)
Labor market (38)
Layoffs (308)
Leadership (15)
Legal (5656)
Licensing (12)
Liver cancer (67)
Longevity (31)
Lung cancer (774)
Lymphoma (401)
Machine learning (46)
Management (9)
Manufacturing (843)
Marketing (12)
MASH (187)
Medical affairs (1)
Medical device (10035)
Medtech (10200)
Mergers & acquisitions (16766)
Metabolic disorders (1242)
mRNA (192)
Multiple sclerosis (158)
NASH (14)
Neurodegenerative disease (441)
Neuropsychiatric disorders (102)
Neuroscience (3035)
Neurotech (1)
NextGen: Class of 2026 (4143)
Non-profit (1531)
Now hiring (42)
Obesity (522)
Opinion (153)
Ovarian cancer (226)
Pain (232)
Pancreatic cancer (317)
Parkinson's disease (373)
Partnered (21)
Patents (593)
Patient recruitment (783)
Peanut (55)
People (49683)
Pharmaceutical (50)
Pharmacy benefit managers (13)
Phase 1 (20995)
Phase 2 (28685)
Phase 3 (19479)
Pipeline (9752)
Policy (119)
Postmarket research (1892)
Preclinical (8958)
Press Release (52)
Prostate cancer (293)
Psychedelics (75)
Radiopharmaceuticals (345)
Rare diseases (1120)
Real estate (3798)
Recruiting (14)
Regulatory (19560)
Reports (33)
Research institute (1330)
Resumes & cover letters (59)
Rett syndrome (49)
RNA editing (31)
RSV (58)
Schizophrenia (173)
Series A (309)
Series B (222)
Service/supplier (5)
Sickle cell disease (118)
Special edition (21)
Spinal muscular atrophy (143)
Sponsored (21)
Startups (3121)
State (1)
Stomach cancer (8)
Supply chain (72)
Tariffs (19)
The Weekly (86)
Vaccines (578)
Venture capital (107)
Weight loss (267)
Women's health (103)
Worklife (3)
Date
Today (74)
Last 7 days (320)
Last 30 days (2058)
Last 365 days (25932)
2026 (16885)
2025 (25861)
2024 (30107)
2023 (34051)
2022 (43405)
2021 (45863)
2020 (41070)
2019 (30078)
2018 (22659)
2017 (24325)
2016 (22772)
2015 (29069)
2014 (25014)
2013 (20781)
2012 (22600)
2011 (22871)
2010 (22510)
Location
Africa (337)
Alabama (93)
Alaska (3)
Arizona (341)
Arkansas (14)
Asia (29160)
Australia (4465)
California (13820)
Canada (3751)
China (1337)
Colorado (565)
Connecticut (538)
Delaware (373)
Europe (54267)
Florida (2028)
Georgia (418)
Hawaii (4)
Idaho (47)
Illinois (931)
India (86)
Indiana (444)
Iowa (18)
Japan (546)
Kansas (116)
Kentucky (36)
Louisiana (42)
Maine (37)
Maryland (1462)
Massachusetts (9946)
Michigan (321)
Minnesota (632)
Mississippi (5)
Missouri (96)
Montana (32)
Nebraska (14)
Nevada (133)
New Hampshire (75)
New Jersey (3217)
New Mexico (19)
New York (3385)
North Carolina (1683)
North Dakota (9)
Northern California (7050)
Ohio (347)
Oklahoma (15)
Oregon (35)
Pennsylvania (2682)
Puerto Rico (24)
Rhode Island (37)
South America (530)
South Carolina (77)
South Dakota (1)
Southern California (5533)
Tennessee (150)
Texas (2205)
United States (46679)
Utah (403)
Vermont (1)
Virginia (247)
Washington D.C. (51)
Washington State (1123)
West Virginia (2)
Wisconsin (110)
Wyoming (1)
584,914 Results for "858 therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amygdala Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for ANS-858
August 18, 2026
·
4 min read
Press Releases
858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, HR+/HER2- Unresectable or Metastatic Breast Cancer
August 18, 2026
·
2 min read
Press Releases
858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting
May 22, 2026
·
3 min read
Press Releases
Novo Nordisk’s adjusted operating profit reached DKK 32,858 million in Q1 2026
May 6, 2026
·
4 min read
Press Releases
Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer
June 2, 2026
·
11 min read
Press Releases
858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer
January 8, 2026
·
2 min read
Press Releases
Emerging Data for Lantern Pharma’s Investigational Drug LP-300 Demonstrates 8.3-Month Median Progression-Free Survival in Patients with EGFR L858R Lung Cancer After Targeted Therapy Failure — With No Added Toxicity
April 20, 2026
·
17 min read
Business
858 Therapeutics Expands Leadership Team to Support Transition to the Clinic
858 Therapeutics is pleased to announce today that it has named Katherine Bell-McGuinn, M.D., Ph.D., as Chief Medical Officer.
December 20, 2023
·
2 min read
Drug Development
858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting
858 Therapeutics today announced an upcoming poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place April 5-10 in San Diego, California.
March 14, 2024
·
2 min read
Press Releases
Stuart Therapeutics, Inc. Appoints David Jakeman as Chief Financial Officer
August 18, 2026
·
3 min read
1 of 58,492
Next
